Show simple item record

dc.contributor.authorJayne, David
dc.contributor.authorBlockmans, Daniel
dc.contributor.authorLuqmani, Raashid
dc.contributor.authorMoiseev, Sergey
dc.contributor.authorJi, Beulah
dc.contributor.authorGreen, Yulia
dc.contributor.authorHall, Leanne
dc.contributor.authorRoth, David
dc.contributor.authorHenderson, Robert B.
dc.contributor.authorMerkel, Peter A.
dc.contributor.authorBREVAS Study Collaborators
dc.date.accessioned2020-03-02T13:55:01Z
dc.date.available2020-03-02T13:55:01Z
dc.date.issued2019-06
dc.identifier.citationJayne , D , Blockmans , D , Luqmani , R , Moiseev , S , Ji , B , Green , Y , Hall , L , Roth , D , Henderson , R B , Merkel , P A & BREVAS Study Collaborators 2019 , ' Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis : A Randomized Controlled Study ' , Arthritis and Rheumatology , vol. 71 , no. 6 , pp. 952-963 . https://doi.org/10.1002/art.40802en
dc.identifier.issn2326-5191
dc.identifier.otherPURE: 158294972
dc.identifier.otherPURE UUID: 04462522-da73-4d44-a8e8-77ad50073106
dc.identifier.otherScopus: 85064637721
dc.identifier.otherPubMed: 30666823
dc.identifier.otherORCID: /0000-0002-2001-3998/work/79062801
dc.identifier.urihttps://hdl.handle.net/2164/13767
dc.descriptionFunding Information: GlaxoSmithKlineen
dc.format.extent12
dc.language.isoeng
dc.relation.ispartofArthritis and Rheumatologyen
dc.rights© 2019 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. https://creativecommons.org/licenses/by-nc-nd/4.0/en
dc.subjectR Medicineen
dc.subjectImmunology and Allergyen
dc.subjectRheumatologyen
dc.subjectImmunologyen
dc.subject.lccRen
dc.titleEfficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis : A Randomized Controlled Studyen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1002/art.40802
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85064637721&partnerID=8YFLogxKen
dc.identifier.vol71en
dc.identifier.iss6en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record